SRSF1 Prevents DNA Damage and Promotes Tumorigenesis through Regulation of DBF4B Pre-mRNA Splicing

被引:69
作者
Chen, Linlin [1 ]
Luo, Chunling [1 ]
Shen, Lei [3 ]
Liu, Yuguo [1 ]
Wang, Qianqian [1 ]
Zhang, Chang [1 ]
Guo, Ruochen [1 ]
Zhang, Yanan [1 ]
Xie, Zhiqin [1 ]
Wei, Ning [1 ]
Wu, Wenwu [2 ]
Han, Jun [3 ]
Feng, Ying [1 ]
机构
[1] Univ Chinese Acad Sci, Shanghai Inst Biol Sci, Chinese Acad Sci, Inst Nutr Sci,Key Lab Food Safety Res, Shanghai, Peoples R China
[2] Zhejiang Agr & Forestry Univ, State Key Lab Subtrop Silviculture, Hangzhou, Zhejiang, Peoples R China
[3] Fudan Univ, Zhongshan Hosp, Dept Gen Surg, Shanghai, Peoples R China
关键词
S-PHASE; PROTEIN; IDENTIFICATION; MECHANISMS; APOPTOSIS; REVEALS; ASF/SF2; EVENTS;
D O I
10.1016/j.celrep.2017.11.091
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Dysregulated alternative splicing events have been implicated in many types of cancer, but the underlying molecular mechanisms remain unclear. Here, we observe that the splicing factor SRSF1 regulates DBF4B exon6 splicing by specifically binding and promoting its inclusion. Knockdown of the exon6-containing isoform (DBF4B-FL) significantly inhibits the tumorigenic potential of colon cancer cells in vitro and in mice, and SRSF1 inactivation phenocopies DBF4B-FL depletion. DBF4B-FL and SRSF1 are required for cancer cell proliferation and for the maintenance of genomic stability. Overexpression of DBF4B-FL can protect against DNA damage induced by SRSF1 knockdown and rescues growth defects in SRSF1-depleted cells. Increased DBF4B exon6 inclusion parallels SRSF1 upregulation in clinical colorectal cancer samples. Taken together, our findings identify SRSF1 as a key regulator of DBF4B pre-mRNA splicing dysregulation in colon cancer, with possible clinical implications as candidate prognostic factors in cancer patients.
引用
收藏
页码:3406 / 3413
页数:8
相关论文
共 22 条
[1]   SRSF1-Regulated Alternative Splicing in Breast Cancer [J].
Anczukow, Olga ;
Akerman, Martin ;
Clery, Antoine ;
Wu, Jie ;
Shen, Chen ;
Shirole, Nitin H. ;
Raimer, Amanda ;
Sun, Shuying ;
Jensen, Mads A. ;
Hua, Yimin ;
Allain, Frederic H. -T. ;
Krainer, Adrian R. .
MOLECULAR CELL, 2015, 60 (01) :105-117
[2]   The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation [J].
Anczukow, Olga ;
Rosenberg, Avi Z. ;
Akerman, Martin ;
Das, Shipra ;
Zhan, Lixing ;
Karni, Rotem ;
Muthuswamy, Senthil K. ;
Krainer, Adrian R. .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2012, 19 (02) :220-228
[3]   Emerging roles of heterogeneous nuclear ribonucleoprotein K (hnRNP K) in cancer progression [J].
Barboro, Paola ;
Ferrari, Nicoletta ;
Balbi, Cecilia .
CANCER LETTERS, 2014, 352 (02) :152-159
[4]   Mechanisms of alternative pre-messenger RNA splicing [J].
Black, DL .
ANNUAL REVIEW OF BIOCHEMISTRY, 2003, 72 :291-336
[5]   Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches [J].
Chen, Mo ;
Manley, James L. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2009, 10 (11) :741-754
[6]   Identification of recurrent regulated alternative splicing events across human solid tumors [J].
Danan-Gotthold, Miri ;
Golan-Gerstl, Regina ;
Eisenberg, Eli ;
Meir, Keren ;
Karni, Rotem ;
Levanon, Erez Y. .
NUCLEIC ACIDS RESEARCH, 2015, 43 (10) :5130-5144
[7]   Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged [J].
David, Charles J. ;
Manley, James L. .
GENES & DEVELOPMENT, 2010, 24 (21) :2343-2364
[8]   Identification of Alternative Splicing Events Regulated by the Oncogenic Factor SRSF1 in Lung Cancer [J].
de Miguel, Fernando J. ;
Sharma, Ravi D. ;
Pajares, Maria J. ;
Montuenga, Luis M. ;
Rubio, Angel ;
Pio, Ruben .
CANCER RESEARCH, 2014, 74 (04) :1105-1115
[9]   The gene encoding the splicing factor SF2/ASF is a proto-oncogene [J].
Karni, Rotem ;
de Stanchina, Elisa ;
Lowe, Scott W. ;
Sinha, Rahul ;
Mu, David ;
Krainer, Adrian R. .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2007, 14 (03) :185-193
[10]   Splicing factors of SR and hnRNP families as regulators of apoptosis in cancer [J].
Kedzierska, Hanna ;
Piekielko-Witkowska, Agnieszka .
CANCER LETTERS, 2017, 396 :53-65